IIS: Current HL7 Standard Code Set
CVX -- Vaccines Administered

The CDC's National Center of Immunization and Respiratory Diseases (NCIRD) developed and maintains the CVX (vaccine administered) code set. The table below has the most up to date values. It includes both active and inactive vaccines available in the US. CVX codes for inactive vaccines allow transmission of historical immunization records. When a MVX (manufacturer) code is paired with a CVX (vaccine administered) code, the specific trade named vaccine may be indicated. These codes should be used for immunization messages using either HL7 Version 2.3.1 or HL7 Version 2.5.1. The version of the CVX code set for certification can be found on the archive page.

The Status column indicates if the vaccine is currently available in the United States.
  • Active: A currently available administrable vaccine
  • Inactive: An administrable vaccine formulation that is no longer available for patient administration, but can be found in historical patient records.
                   OR A historical record of a vaccine administered where the exact formulation is unknown
  • Pending: A vaccine that is expected to become active in the future
  • Non-US: A vaccine that available outside the US only
  • Never Active: A vaccine that was never available and is not in the pipeline of new vaccines

The Last Updated column indicates the last time this particular vaccine code was updated in this table.

Questions regarding this table should be directed to the IIS Technical Assistance Team(or use mailing address).

Sort Table by Column: Simply click on the column heading to sort the table accordingly.

Short DescriptionFull Vaccine nameCVX CodeVaccine StatusLast Updated
Date
Notes
Adenovirus types 4 and 7Adenovirus, type 4 and type 7, live, oral143 Active3/20/2011This vaccine is administered as 2 tablets.
adenovirus, type 4adenovirus vaccine, type 4, live, oral54 Inactive5/28/2010
adenovirus, type 7adenovirus vaccine, type 7, live, oral55 Inactive5/28/2010
adenovirus, unspecified formulationadenovirus vaccine, unspecified formulation82 Inactive9/30/2010This CVX code allows reporting of a vaccination when formulation is unknown (for example, when recording a adenovirus vaccination when noted on a vaccination card)
Anthrax, post-exposure prophylaxisAnthrax vaccine, adsorbed, adjuvanted, post-exposure prophylaxis318 Active1/25/2024National stockpile vaccine (Cyfendus)
Anthrax, pre-exposure prophylaxis, post-exposure prophylaxisAnthrax vaccine, adsorbed, pre-exposure and post-exposure prophylaxis24 Active1/25/2024
BCGBacillus Calmette-Guerin vaccine19 Active5/28/2010
Chikungunya live attenuated vaccine, 0.5 mL, PFChikungunya, live attenuated vaccine, 0.5 mL, preservative free317 Active12/20/2023Chikungunya Vaccine
cholera, BivWCcholera, BivWC173 Non-US6/17/2016
cholera, live attenuatedcholera, live attenuated174 Active6/17/2016
cholera, unspecified formulationcholera vaccine, unspecified formulation26 Inactive6/17/2016
cholera, WC-rBScholera, WC-rBS172 Non-US6/17/2016
COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC)SARS-COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC)516 Non-US4/12/2022Pandemic Non-US Vaccine not Authorized by WHO - not counted toward immunity in US
COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva)SARS-COV-2 COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva)518 Non-US11/17/2022Pandemic Non-US Vaccine not Authorized by WHO - not counted toward immunity in US
COVID-19 IV Non-US Vaccine (BIBP, Sinopharm)SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (BIBP, Sinopharm)510 Non-US11/15/2022Pandemic Non-US Vaccine. Authorized by WHO - Counted toward immunity in US
COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac)SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (CoronaVac, Sinovac)511 Non-US11/15/2022Pandemic Non-US Vaccine. Authorized by WHO - Counted toward immunity in US
COVID-19 IV Non-US Vaccine (COVAXIN)SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (COVAXIN)502 Non-US11/19/2021Pandemic Non-US Vaccine Authorized by WHO 11-3-2021, recognized toward immunity in US, https://extranet.who.int/pqweb/vaccines/who-recommendation-bharat-biotech-international-ltd-covid-19-vaccine-whole-virion
COVID-19 IV Non-US Vaccine (QAZCOVID-IN)SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (QAZCOVID-IN)501 Non-US7/15/2021Pandemic Non-US Vaccine not Authorized by WHO - not counted toward immunity in US
COVID-19 LAV Non-US Vaccine (COVIVAC)SARS-COV-2 COVID-19 Live Attenuated Virus Non-US Vaccine Product (COVIVAC)503 Non-US1/3/2024Pandemic Non-US Vaccine not Authorized by WHO - not counted toward immunity in US
COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), ModernaSARS-COV-2 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna519 Non-US11/17/2022Pandemic Non-US Vaccine not Authorized by WHO - Is authorized by EU and counted toward immunity in US
COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product, Pfizer-BioNTechSARS-COV-2 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product (Comirnaty Bivalent), Pfizer-BioNTech520 Non-US12/19/2022Pandemic Non-US Vaccine. Authorized by WHO 10/19/2022 - Counted toward immunity in US
COVID-19 Non-US Vaccine, Product UnknownSARS-COV-2 COVID-19 Non-US Vaccine, Specific Product Unknown500 Non-US7/15/2021Pandemic Non-US Covid Administration - specific CVX or product unknown
COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom Biopharm + Inst of Micro, Chinese Acad of Sciences)SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom Biopharmaceutical + Institute of Microbiology, Chinese Academy of Sciences)507 Non-US8/18/2021Pandemic Non-US Vaccine not Authorized by WHO - not counted toward immunity in US
COVID-19 PS Non-US Vaccine (EpiVacCorona)SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (EpiVacCorona)509 Non-US7/15/2021Pandemic Non-US Vaccine not Authorized by WHO - not counted toward immunity in US
COVID-19 PS Non-US Vaccine (Jiangsu Province Centers for Disease Control and Prevention)SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Jiangsu Province Centers for Disease Control and Prevention)508 Non-US1/3/2024Pandemic Non-US Vaccine not Authorized by WHO - not counted toward immunity in US
COVID-19 SP, protein-based, adjuvanted (VidPrevtyn Beta), Sanofi-GSKSARS-COV-2 (COVID-19) vaccine SP, protein-based, adjuvanted, B.1.351 strain (VidPrevtyn Beta), Sanofi-GSK521 Non-US1/3/2024Pandemic Non-US Vaccine not Authorized by WHO - not counted toward immunity in US
COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mLSARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-Ad26, preservative free, 0.5 mL212 Inactive10/26/2023Original monovalent Janssen/J&J adult vaccine. All NDCs expired 6/20/2023, not reauthorized by FDA for Fall 2023 US doses. Continue to use to record Jansses/J&J Non-US vaccines administered vaccines administered
COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mLSARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-ChAdOx1, preservative free, 0.5 mL210 Non-US1/3/2024WHO authorized pandemic vaccine. Recognized towards immunity in US. AstraZeneca vaccine non-US WHO authorized tradenames/identifiers include VAXZEVRIA, AZD1222, ChAdOx1 nCoV-19, COVISHIELD
COVID-19 VVnr Non-US Vaccine (CanSino Biological Inc./Beijing Institute of BiotechnologySARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (CONVIDECIA), CanSino Biological Inc./Beijing Institute of Biotechnology506 Non-US12/16/2022Pandemic Non-US Vaccine. Authorized by WHO 5/19/2022 - Counted toward immunity in US
COVID-19 VVnr Non-US Vaccine (Sputnik Light)SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (Sputnik Light)504 Non-US7/15/2021Pandemic Non-US Vaccine not Authorized by WHO - not counted toward immunity in US
COVID-19 VVnr Non-US Vaccine (Sputnik V)SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (Sputnik V)505 Non-US7/15/2021Pandemic Non-US Vaccine not Authorized by WHO - not counted toward immunity in US
COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 10mcg/0.5mLSARS-COV-2 (COVID-19) vaccine, D614, prefusion spike recombinant protein subunit (CoV2 preS dTM), AS03 adjuvant added, preservative free, 10mcg/0.5mL dose226 Never Active3/9/2023EUA submission withdrawn by Sanofi
COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 5mcg/0.5mLSARS-COV-2 (COVID-19) vaccine, D614, prefusion spike recombinant protein subunit (CoV2 preS dTM), AS03 adjuvant added, preservative free, 5mcg/0.5mL dose225 Never Active3/9/2023EUA submission withdrawn by Sanofi
COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mLSARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 10 mcg/0.2 mL dose230 Inactive10/26/2023Original strain + omicron BA.4/BA.5 bivalent Moderna vaccine (6 mo through 5 yrs), FDA rescinded 9/11/2023
COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL doseSARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 10 mcg/0.2 mL dose, tris-sucrose formulation301 Inactive10/26/2023Original strain + omicron BA.4/BA.5 bivalent Pfizer vaccine (5 yrs through 11 yrs), FDA rescinded 9/11/2023
COVID-19, mRNA, LNP-S, bivalent, PF, 3 mcg/0.2 mL doseSARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 3 mcg/0.2 mL dose, tris-sucrose formulation302 Inactive10/26/2023Original strain + omicron BA.4/BA.5 bivalent Pfizer vaccine (6 mo through 4 yrs), FDA rescinded 09/11/2023
COVID-19, mRNA, LNP-S, bivalent, PF, 30 mcg/0.3 mL doseSARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 30 mcg/0.3 mL dose, tris-sucrose formulation300 Inactive10/26/2023Original strain + omicron BA.4/BA.5 bivalent Pfizer vaccine (12 yrs and older). FDA rescinded 09/11/2023. Continue to use to record Non-US vaccines administered (tradename Comirnaty Bivalent)
COVID-19, mRNA, LNP-S, bivalent, PF, 50 mcg/0.5 mL or 25mcg/0.25 mL doseSARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 50 mcg/0.5 mL or 25 mcg/0.25 mL dose229 Inactive10/26/2023Original strain + omicron BA.4/BA.5 bivalent Moderna vaccine (6 mo and older), FDA rescinded 9/11/2023. Continue to use to record Non-US vaccines administered (tradename Spikevax Bivalent)
COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL dose, tris-sucroseSARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 10 mcg/0.2mL dose, tris-sucrose formulation218 Inactive10/25/2023Original monovalent Pfizer tris-sucrose formulation (5 yrs through 11 yrs), FDA rescinded 4/18/2023
COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5mL dose or 50 mcg/0.25mL doseSARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose207 Inactive10/24/2023Original monovalent Moderna adult vaccine. FDA rescinded all doses for US use 4/18/2023. Continue to used to record historic US Moderna vaccines and those administered in non-US locations (includes tradename Spikevax)
COVID-19, mRNA, LNP-S, PF, 25 mcg/0.25 mLSARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 25 mcg/0.25 mL dose311 Active9/13/2023Moderna Fall 2023 6 months through 11 years of age
COVID-19, mRNA, LNP-S, PF, 3 mcg/0.2 mL dose, tris-sucroseSARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 3 mcg/0.2mL dose, tris-sucrose formulation219 Inactive10/26/2023Original monovalent Pfizer tris-sucrose formulation (6 mo through 4 yrs), FDA rescinded 4/18/2023
COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL doseSARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose208 Inactive11/14/2023Original monovalent Pfizer adult vaccine (12+ yrs). FDA rescinded all doses for US use 4/18/2023. Continue to use to record historic US Pfizer vaccines and Non-US vaccines administered (includes tradename Comirnaty)
COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucroseSARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose, tris-sucrose formulation217 Inactive11/2/2023Original monovalent Pfizer tris-sucrose formulation FDA EUA (12+ yrs) and BLA (16+ yrs), FDA rescinded monovalent use 08/31/2022, BLA NDCs not retired until 09/11/2023.
COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mLSARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 50 mcg/0.5 mL dose312 Active9/13/2023Moderna Fall 2023 12 years and older
COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL doseSARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 50 mcg/0.5 mL dose221 Inactive10/25/2023Original monovalent Moderna, (Adult) FDA rescinded 4/18/2023, (6 yrs through 11 yrs) FDA rescinded 04/18/2023
COVID-19, mRNA, LNP-S, PF, pediatric 25 mcg/0.25 mL doseSARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, pediatric 25 mcg/0.25 mL dose228 Inactive10/27/2023Original monovalent Moderna pediatric vaccine (6 mo through 5 yrs), FDA rescinded 4/18/2023
COVID-19, mRNA, LNP-S, PF, pediatric 50 mcg/0.5 mL doseSARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, pediatric 50 mcg/0.5 mL dose227 Inactive10/26/2023Original monovalent Moderna pediatric vaccine (FDA rescinded 4/18/2023). Inactivated 6/14/2022 to use CVX code 221 product instead
COVID-19, mRNA, LNP-S, PF, tris-sucrose, 10 mcg/0.3 mLSARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 10 mcg/0.3 mL dose310 Active9/13/2023Pfizer Fall 2023 5 years through 11 years of age
COVID-19, mRNA, LNP-S, PF, tris-sucrose, 3 mcg/0.3 mLSARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 3 mcg/0.3 mL dose308 Active9/13/2023Pfizer Fall 2023 6 months through 4 years of age
COVID-19, mRNA, LNP-S, PF, tris-sucrose, 30 mcg/0.3 mLSARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 30 mcg/0.3 mL dose309 Active9/13/2023Pfizer Fall 2023 12 years and older
COVID-19, subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mLSARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 0.5mL dose211 Inactive10/24/2023Original monovalent Novavax vaccine (12+ years), FDA rescinded for US doses 10/03/2023. Continue to use to record Novavax Non-US vaccines administered (includes tradenames NUVAXOVID, COVOVAX)
COVID-19, subunit, rS-nanoparticle, adjuvanted, PF, 5 mcg/0.5 mLSARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 5 mcg/0.5 mL dose313 Active9/1/2023Novavax Fall 2023 12 years and older
dengue fever tetravalentdengue fever vaccine, tetravalent56 Active2/16/2023Applies to tetravalent product (e.g. DENGVAXIA)
DT (pediatric)diphtheria and tetanus toxoids, adsorbed for pediatric use28 Active5/28/2010
DT, IPV adsorbedDiphtheria, Tetanus, Poliomyelitis adsorbed195 Non-US1/17/2023This code should be used to document non-US vaccines for DT,IPV such as Revaxis
DTaPdiphtheria, tetanus toxoids and acellular pertussis vaccine20 Active5/28/2010
DTaP, 5 pertussis antigensdiphtheria, tetanus toxoids and acellular pertussis vaccine, 5 pertussis antigens106 Active5/28/2010
DTaP, unspecified formulationdiphtheria, tetanus toxoids and acellular pertussis vaccine, unspecified formulation107 Inactive9/30/2010This CVX code allows reporting of a vaccination when formulation is unknown (for example, when recording a DTaP vaccination when noted on a vaccination card)
DTaP,IPV,Hib,HepBDiphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate (Meningococcal Protein Conjugate), and Hepatitis B (Recombinant) Vaccine.146 Active8/10/2022This vaccine is different from CVX 132. Code may be used to document non-US vaccines (e.g. Hexamin) of the same component formulation
DTaP-Hep B-IPVDTaP-hepatitis B and poliovirus vaccine110 Active5/28/2010
DTaP-HibDTaP-Haemophilus influenzae type b conjugate vaccine50 Inactive3/20/2017
DTaP-Hib-IPVdiphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV)120 Active5/28/2010
DTaP-IPVDiphtheria, tetanus toxoids and acellular pertussis vaccine, and poliovirus vaccine, inactivated130 Active5/28/2010
DTaP-IPV-HIB-HEP B, historicalHistorical diphtheria and tetanus toxoids and acellular pertussis, poliovirus, Haemophilus b conjugate and hepatitis B (recombinant) vaccine.132 Inactive5/10/2018This is not the same as CVX 146, Hexavalent vaccine.
DTAP/IPV/HIB - non-USnon-US diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV)170 Non-US5/20/2016This CVX was split off from CVX 102, to correctly identify the contents of the vaccine.
DTPdiphtheria, tetanus toxoids and pertussis vaccine01 Inactive5/28/2010
DTP-hepB-Hib Pentavalent Non-USDiphtheria, pertussis, tetanus, hepatitis B, Haemophilus Influenza Type b, (Pentavalent)198 Non-US1/17/2023This represents the non-US pentavalent vaccine. Should be used for historic documentation in US
DTP-HibDTP-Haemophilus influenzae type b conjugate vaccine22 Inactive3/23/2017
DTP-Hib-Hep BDTP- Haemophilus influenzae type b conjugate and hepatitis b vaccine102 Non-US5/20/2016This CVX has been corrected. This non-US vaccine contained DTP, Hib and Hep B. It was withdrawn in 2007 .
Ebola Zaire vaccine, live, recombinant, 1mL doseEbola Zaire vaccine, live, recombinant, 1mL dose204 Active1/3/2024FDA Approved ERVEBO Vaccine.
Ebola, unspecifiedEbola, unspecified214 Inactive4/6/2021
hantavirushantavirus vaccine57 Never Active9/9/2020
Hep A, adulthepatitis A vaccine, adult dosage52 Active5/28/2010
Hep A, live attenuatedHep A, live attenuated-IM169 Non-US5/10/2016This vaccine is not available in the US.
Hep A, ped/adol, 2 dosehepatitis A vaccine, pediatric/adolescent dosage, 2 dose schedule83 Active5/28/2010
Hep A, ped/adol, 3 dosehepatitis A vaccine, pediatric/adolescent dosage, 3 dose schedule84 Inactive5/28/2010This vaccine formulation is inactive and should not be used, except to record historic vaccinations with this formulation.
Hep A, pediatric, unspecified formulationhepatitis A vaccine, pediatric dosage, unspecified formulation31 Inactive9/30/2010Do NOT use this code. If formulation is unknown, use CVX 85. There is only one formulation of Hep A, peds.
Hep A, unspecified formulationhepatitis A vaccine, unspecified formulation85 Inactive9/30/2010This CVX code allows reporting of a vaccination when formulation is unknown (for example, when recording a HepA vaccination when noted on a vaccination card)
Hep A-Hep Bhepatitis A and hepatitis B vaccine104 Active5/28/2010
Hep A-Hep B, pediatric/adolescenthepatitis A and hepatitis B vaccine, pediatric/adolescent (non-US)193 Non-US8/21/2018e.g. Twinrix Junior available in Canada
Hep B, adolescent or pediatrichepatitis B vaccine, pediatric or pediatric/adolescent dosage08 Active5/10/2018This code applies to any standard pediatric formulation of Hepatitis B vaccine. It should not be used for the 2-dose hepatitis B schedule for adolescents (11-15 year olds). It requires Merck's Recombivax HB adult formulation. Use code 43 for that vaccine.
Hep B, adolescent/high risk infanthepatitis B vaccine, adolescent/high risk infant dosage42 Inactive5/28/2010As of August 27, 1998, Merck ceased distribution of their adolescent/high risk infant hepatitis B vaccine dosage. Code 42 should only be used to record historical records. For current administration of hepatitis B vaccine, pediatric/adolescent dosage, use code 08.
Hep B, adulthepatitis B vaccine, adult dosage43 Active5/10/2018As of September 1999, a 2-dose hepatitis B schedule for adolescents (11-15 year olds) was FDA approved for Merck's Recombivax HB adult formulation. Use code 43 for the 2-dose. This code should be used for any use of standard adult formulation of hepatitis B vaccine.
Hep B, dialysishepatitis B vaccine, dialysis patient dosage44 Active5/8/2019NDCs that are used for both vaccine and dialysis (e.g. Engerix-B) are mapped to CVX 43 which is not specific to dialysis use
Hep B, unspecified formulationhepatitis B vaccine, unspecified formulation45 Inactive9/30/2010This CVX code allows reporting of a vaccination when formulation is unknown (for example, when recording a HepB vaccination when noted on a vaccination card)
Hep Chepatitis C vaccine58 Never Active9/9/2020
Hep Ehepatitis E vaccine59 Never Active9/9/2020
HepB recombinant, 3-antigen, Al(OH)3Hepatitis B vaccine (recombinant), 3-antigen, Al(OH)3 adjuvanted220 Active2/14/2022New Hep B vaccine 1/2022
HepB-CpGHepatitis B vaccine (recombinant), CpG adjuvanted189 Active5/10/2018
herpes simplex 2herpes simplex virus, type 2 vaccine60 Never Active9/9/2020
Hib (HbOC)Haemophilus influenzae type b vaccine, HbOC conjugate47 Inactive5/28/2010
Hib (PRP-D)Haemophilus influenzae type b vaccine, PRP-D conjugate46 Inactive5/28/2010
Hib (PRP-OMP)Haemophilus influenzae type b vaccine, PRP-OMP conjugate49 Active5/28/2010
Hib (PRP-T)Haemophilus influenzae type b vaccine, PRP-T conjugate48 Active5/28/2010
Hib, unspecified formulationHaemophilus influenzae type b vaccine, conjugate unspecified formulation17 Inactive9/30/2010
Hib-Hep BHaemophilus influenzae type b conjugate and Hepatitis B vaccine51 Inactive3/11/2016This vaccine may still be in use until the existing lots expire on 8/19/16.
HIVhuman immunodeficiency virus vaccine61 Never Active9/9/2020
HPV, bivalenthuman papilloma virus vaccine, bivalent118 Inactive5/28/2010
HPV, quadrivalenthuman papilloma virus vaccine, quadrivalent62 Active6/2/2020
HPV, unspecified formulationHPV, unspecified formulation137 Inactive9/30/2010This CVX code allows reporting of a vaccination when formulation is unknown (for example, when recording a HPV vaccination when noted on a vaccination card)
HPV9Human Papillomavirus 9-valent vaccine165 Active12/11/2014
Influenza A monovalent (H5N1), ADJUVANTED-2013Influenza A monovalent (H5N1), adjuvanted, National stockpile 2013160 Active5/27/2014Approved by FDA 2013, adjuvant is mixed at point of administration.
influenza nasal, unspecified formulationinfluenza nasal, unspecified formulation151 Inactive1/28/2013This CVX should only be used for historical records where the formulation of nasal flu vaccine is not known.
Influenza vaccine, quadrivalent, adjuvantedinfluenza, seasonal vaccine, quadrivalent, adjuvanted, 0.5mL dose, preservative free205 Active1/17/2023
influenza, H5N1-1203influenza virus vaccine, H5N1, A/Vietnam/1203/2004 (national stockpile)123 Inactive5/28/2010
Influenza, high dose seasonalinfluenza, high dose seasonal, preservative-free135 Active5/28/2010
influenza, high-dose, quadrivalentinfluenza, high-dose seasonal, quadrivalent, 0.7mL dose, preservative free197 Active1/17/2023Target population 65 and older, starting season 2020/2021
Influenza, injectable, MDCK, preservative freeInfluenza, injectable, Madin Darby Canine Kidney, preservative free153 Inactive6/24/2016ccIIV3
Influenza, injectable, MDCK, preservative free, quadrivalentInfluenza, injectable, Madin Darby Canine Kidney, preservative free, quadrivalent171 Active1/25/2024
Influenza, injectable, MDCK, quadrivalent, preservativeInfluenza, injectable, Madin Darby Canine Kidney, quadrivalent with preservative186 Active1/25/2024
influenza, injectable, quadrivalentinfluenza, injectable, quadrivalent, contains preservative158 Active8/20/2013New in 2013. IIV4
influenza, injectable, quadrivalent, preservative freeInfluenza, injectable, quadrivalent, preservative free150 Active7/17/2013New in 2012. IIV4
Influenza, injectable,quadrivalent, preservative free, pediatricInfluenza, injectable,quadrivalent, preservative free, pediatric161 Active7/23/2014
influenza, intradermal, quadrivalent, preservative freeinfluenza, intradermal, quadrivalent, preservative free, injectable166 Inactive12/15/2022No US product available since 2017/2018 flu season
influenza, live, intranasalinfluenza virus vaccine, live, attenuated, for intranasal use111 Inactive9/22/2014LAIV3
influenza, live, intranasal, quadrivalentinfluenza, live, intranasal, quadrivalent149 Active7/17/2013new in 2012. LAIV4
influenza, recombinant, injectable, preservative freeSeasonal, trivalent, recombinant, injectable influenza vaccine, preservative free155 Active7/17/2013RIV
influenza, recombinant, quadrivalent,injectable, preservative freeSeasonal, quadrivalent, recombinant, injectable influenza vaccine, preservative free185 Active4/21/2017
Influenza, seasonal, injectableInfluenza, seasonal, injectable141 Active7/17/2013IIV3. This is one of two codes replacing CVX 15, which is being retired.
Influenza, seasonal, injectable, preservative freeInfluenza, seasonal, injectable, preservative free140 Inactive12/15/2022IIV3. No US product available since 2018/2019 flu season. This vaccine code is one of two which replace CVX 15, influenza, split virus.
influenza, seasonal, intradermal, preservative freeseasonal influenza, intradermal, preservative free144 Inactive12/15/2022IIV3. No US product available since 2014/2015 flu season
Influenza, Southern Hemisphereinfluenza, Southern Hemisphere, unspecified formulation194 Inactive7/16/2020This CVX code should be used to record administration of Southern Hemisphere influenza vaccine where formulation is unknown
influenza, Southern Hemisphere, high-dose, quadrivalentinfluenza, seasonal, Southern Hemisphere, high-dose, quadrivalent, 0.7mL dose, preservative free231 Active3/14/2023Target population 65 and older, starting Southern Hemisphere season 2023
influenza, Southern Hemisphere, pediatric, preservative freeinfluenza, seasonal, Southern Hemisphere, quadrivalent, pediatric 0.25mL dose, preservative free200 Active1/17/2023Pediatric dose for ages 6-35 months
influenza, Southern Hemisphere, preservative freeinfluenza, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, no preservative201 Active1/17/2023Represents single dose vial
influenza, Southern Hemisphere, quadrivalent, with preservativeinfluenza, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, with preservative202 Active1/17/2023Represents multi-dose vial
influenza, split (incl. purified surface antigen)influenza virus vaccine, split virus (incl. purified surface antigen)-retired CODE15 Inactive9/30/2010This code is being retired. It will still be found in older immunization records. It included both preservative free and non-preservative free.
influenza, trivalent, adjuvantedSeasonal trivalent influenza vaccine, adjuvanted, preservative free168 Active12/10/2015
influenza, unspecified formulationinfluenza virus vaccine, unspecified formulation88 Inactive9/30/2010This CVX code allows reporting of a vaccination when formulation is unknown (for example, when recording a Influenza vaccination when noted on a vaccination card)
influenza, wholeinfluenza virus vaccine, whole virus16 Inactive5/28/2010
IPVpoliovirus vaccine, inactivated10 Active5/28/2010
Japanese Encephalitis IMJapanese Encephalitis vaccine for intramuscular administration134 Active5/28/2010
Japanese encephalitis SCJapanese Encephalitis Vaccine SC39 Inactive9/24/2015
Japanese Encephalitis, unspecified formulationJapanese Encephalitis vaccine, unspecified formulation129 Inactive9/30/2010This CVX code allows reporting of a vaccination when formulation is unknown (for example, when recording a JE vaccination when noted on a vaccination card)
Junin virusJunin virus vaccine63 Never Active9/9/2020
leishmaniasisleishmaniasis vaccine64 Never Active9/9/2020
leprosyleprosy vaccine65 Never Active9/9/2020
Lyme diseaseLyme disease vaccine66 Inactive5/28/2010
M/Rmeasles and rubella virus vaccine04 Inactive5/28/2010
malariamalaria vaccine67 Never Active9/9/2020
measlesmeasles virus vaccine05 Inactive8/31/2010
melanomamelanoma vaccine68 Never Active9/9/2020
meningococcal A polysaccharide (non-US)meningococcal A polysaccharide vaccine (non-US)191 Non-US5/10/2018
meningococcal AC polysaccharide (non-US)meningococcal AC polysaccharide vaccine (non-US)192 Non-US5/10/2018
meningococcal ACWY, unspecified formulationmeningococcal ACWY vaccine, unspecified formulation108 Inactive12/1/2015This CVX is intended for use when one of the meningococcal vaccines containing serogroups A, C, W and Y (conjugate or polysaccaride) was given and the exact formulation was not recorded. It should not be used to record newly administered immunizations. It is not to be used when one of the meningococcal vaccines containing other serogroups was administered.
meningococcal B, OMVmeningococcal B vaccine, recombinant, OMV, adjuvanted163 Active2/2/2015
meningococcal B, recombinantmeningococcal B vaccine, fully recombinant162 Active11/3/2014
meningococcal B, unspecifiedmeningococcal B, unspecified formulation164 Inactive11/3/2014
meningococcal C conjugatemeningococcal C conjugate vaccine103 Inactive5/28/2010
Meningococcal C/Y-HIB PRPMeningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine148 Inactive5/11/2018
meningococcal conjugate quadrivalent, MenACWY-TT (MCV4)meningococcal polysaccharide (groups A, C, Y, W-135) tetanus toxoid conjugate vaccine 0.5mL dose, preservative free203 Active1/26/2023
meningococcal MCV4, unspecified formulationMeningococcal, MCV4, unspecified conjugate formulation(groups A, C, Y and W-135)147 Inactive2/8/2012This CVX should only be used for historical doses of meningococcal conjugate vaccine where the formulation is unknown (oligosaccharide vs polysaccharide). It is not the same as CVX 108, Meningococcal, unspecified formulation. This CVX is for unspecified Meningococcal conjugate vaccines.
Meningococcal MCV4Omeningococcal oligosaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4O)136 Active5/28/2010
meningococcal MCV4Pmeningococcal polysaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4P)114 Active5/28/2010
meningococcal MPSV4meningococcal polysaccharide vaccine (MPSV4)32 Inactive10/27/2017
Meningococcal polysaccharide (MenACWY-TT conjugate), (MenB), PFMeningococcal polysaccharide (groups A, C, Y, W) tetanus toxoid conjugate, meningococcal B recombinant vaccine, 0.5mL, preservative free316 Active1/25/2024Meningococcal pentavalent vaccine strains ABCW and Y
meningococcal, unknown serogroupsmeningococcal vaccine of unknown formulation and unknown serogroups167 Inactive12/1/2015This CVX is intended for use when any one of the meningococcal vaccines is recorded and there is no information about which serogroups are protected against. This code should not be used when a newly administered immunization is recorded.
MMRmeasles, mumps and rubella virus vaccine03 Active5/28/2010
MMRVmeasles, mumps, rubella, and varicella virus vaccine94 Active5/28/2010
mumpsmumps virus vaccine07 Inactive6/18/2015
Novel influenza-H1N1-09Novel influenza-H1N1-09, injectable127 Inactive8/28/2010
Novel Influenza-H1N1-09, all formulationsNovel influenza-H1N1-09, all formulations128 Inactive8/28/2010This code is used whenever the actual formulation is not determined or when aggregating all Novel H1N1 Influenza-09 immunizations for reporting to CRA. It should not be used for seasonal influenza vaccine that is not otherwise specified. (NOS)
Novel Influenza-H1N1-09, nasalNovel Influenza-H1N1-09, live virus for nasal administration125 Inactive8/28/2010
Novel influenza-H1N1-09, preservative-freeNovel influenza-H1N1-09, preservative-free, injectable126 Inactive8/28/2010
OPVtrivalent poliovirus vaccine, live, oral02 Inactive2/10/2017This is the OPV that was used in the US
OPV ,monovalent, unspecifiedNon-US monovalent oral polio vaccine, unspecified formulation179 Non-US1/17/2017This is a non-US vaccine that may be seen in some immunization histories. It is composed of either Type 1, Type 2 or Type 3 oral polio vaccine.
OPV bivalentNon-US bivalent oral polio vaccine (types 1 and 3)178 Non-US1/17/2017This is a non-US vaccine that may be seen in some immunization histories.
OPV, UnspecifiedOral Polio Vaccine, Unspecified formulation182 Inactive1/17/2017This code represents an oral polio vaccine where the specific formulation is unknown.
parainfluenza-3parainfluenza-3 virus vaccine69 Inactive5/28/2010
PCV10pneumococcal conjugate vaccine, 10 valent177 Non-US12/19/2016This is a foreign vaccine
pertussispertussis vaccine11 Inactive5/28/2010
plagueplague vaccine23 Inactive5/17/2018
Pneumococcal conjugate PCV 13pneumococcal conjugate vaccine, 13 valent133 Active5/28/2010
pneumococcal conjugate PCV 7pneumococcal conjugate vaccine, 7 valent100 Inactive6/26/2014
Pneumococcal conjugate PCV15, polysaccharide CRM197 conjugate, adjuvant, PFPneumococcal conjugate vaccine 15-valent (PCV15), polysaccharide CRM197 conjugate, adjuvant, preservative free215 Active8/18/2021
Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PFPneumococcal conjugate vaccine 20-valent (PCV20), polysaccharide CRM197 conjugate, adjuvant, preservative free216 Active3/9/2023
Pneumococcal Conjugate, unspecified formulationPneumococcal Conjugate, unspecified formulation152 Inactive1/28/2013This CVX should only be used for historical records where the formulation of pneumococcal conjugate vaccine is not known.
pneumococcal polysaccharide PPV23pneumococcal polysaccharide vaccine, 23 valent33 Active5/28/2010
pneumococcal, unspecified formulationpneumococcal vaccine, unspecified formulation109 Inactive9/30/2010This CVX code allows reporting of a vaccination when formulation is unknown (for example, when recording a pneumococcal vaccination when noted on a vaccination card)
polio, unspecified formulationpoliovirus vaccine, unspecified formulation89 Inactive9/30/2010This CVX code allows reporting of a vaccination when formulation is unknown (for example, when recording a polio vaccination when noted on a vaccination card)
Q feverQ fever vaccine70 Never Active9/9/2020
Rabies - IM Diploid cell cultureHuman Rabies vaccine from human diploid cell culture175 Active10/18/2016
Rabies - IM fibroblast cultureHuman rabies vaccine from Chicken fibroblast culture176 Active10/18/2016
rabies, intradermal injectionrabies vaccine, for intradermal injection40 Inactive6/18/2015
rabies, intramuscular injectionrabies vaccine, for intramuscular injection RETIRED CODE18 Inactive10/18/2016This CVX code has been retired. It is replace by CVX 175, or CVX 176. It will continue to be found in historic records.
rabies, unspecified formulationrabies vaccine, unspecified formulation90 Inactive9/30/2010This CVX code allows reporting of a vaccination when formulation is unknown (for example, when recording a rabies vaccination when noted on a vaccination card)
Respiratory syncytial virus (RSV) MAB, unspecifiedRespiratory syncytial virus (RSV) monoclonal antibody (MAB), unspecified315 Inactive9/19/2023Unspecified, for historic records where the specific RSV MAB administered is not known
Respiratory syncytial virus (RSV) vaccine, unspecifiedRespiratory syncytial virus (RSV) vaccine, unspecified314 Inactive9/19/2023Unspecified, for historic records where the specific vaccine administered is not known
Respiratory syncytial virus (RSV), unspecifiedRespiratory syncytial virus (RSV), unspecified304 Inactive1/3/2024Unspecified, for historic records where it is not known if RSV vaccine or RSV MAB was administered
rheumatic feverrheumatic fever vaccine72 Never Active9/9/2020
Rift Valley feverRift Valley fever vaccine73 Never Active9/9/2020
rotavirus, monovalentrotavirus, live, monovalent vaccine119 Active5/28/2010
rotavirus, pentavalentrotavirus, live, pentavalent vaccine116 Active5/28/2010
rotavirus, tetravalentrotavirus, live, tetravalent vaccine74 Inactive5/28/2010
rotavirus, unspecified formulationrotavirus vaccine, unspecified formulation122 Inactive9/30/2010
RSV, bivalent, protein subunit RSVpreF, diluent reconstituted, 0.5 mL, PFRespiratory syncytial virus (RSV), vaccine, bivalent, protein subunit RSV prefusion F, diluent reconstituted, 0.5 mL, preservative free305 Active7/13/2023Adults 60 years and older
RSV, mAb, nirsevimab-alip, 0.5 mL, neonate to 24 monthsRespiratory syncytial virus (RSV) monoclonal antibody, IgG1κ , (nirsevimab-alip), 0.5 mL, neonates and children to 24 months306 Active7/25/2023RSV monoclonal antibody (Beyfortus)
RSV, mAb, nirsevimab-alip, 1 mL, neonate to 24 monthsRespiratory syncytial virus (RSV) monoclonal antibody, IgG1κ , (nirsevimab-alip), 1 mL, neonates and children to 24 months307 Active8/9/2023RSV monoclonal antibody (Beyfortus)
RSV, recombinant, protein subunit RSVpreF, adjuvant reconstituted, 0.5 mL, PFRespiratory syncytial virus (RSV), vaccine, recombinant, protein subunit RSV prefusion F, adjuvant reconstituted, 0.5 mL, preservative free303 Active6/6/2023Adults 60 years and older
rubellarubella virus vaccine06 Inactive6/18/2015
rubella/mumpsrubella and mumps virus vaccine38 Inactive5/28/2010
SARS-COV-2 (COVID-19) vaccine, UNSPECIFIEDSARS-COV-2 (COVID-19) vaccine, UNSPECIFIED213 Inactive7/31/2021Unspecified code for COVID-19 not to be used to record patient US administration. May be used to record historic US administration if product not known. CVX code 500 should be used to record Non-US vaccine where product is not known.
SARS-COV-2 COVID-19 DNA Non-US Vaccine (Zydus Cadila, ZyCoV-D)SARS-COV-2 COVID-19 DNA Non-US Vaccine Product (Zydus Cadila, ZyCoV-D)514 Non-US4/12/2022Pandemic Non-US Vaccine not Authorized by WHO - not counted toward immunity in US
SARS-COV-2 COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom, Zifivax)SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom, Zifivax)513 Non-US4/12/2022Pandemic Non-US Vaccine not Authorized by WHO - not counted toward immunity in US
SARS-COV-2 COVID-19 PS Non-US Vaccine (Biological E Limited, Corbevax)SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Biological E Limited, Corbevax)517 Non-US4/12/2022Pandemic Non-US Vaccine not Authorized by WHO - not counted toward immunity in US
SARS-COV-2 COVID-19 PS Non-US Vaccine (Medigen, MVC-COV1901)SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Medigen, MVC-COV1901)515 Non-US4/12/2022Pandemic Non-US Vaccine not Authorized by WHO - not counted toward immunity in US
SARS-COV-2 COVID-19 VLP Non-US Vaccine (Medicago, Covifenz)SARS-COV-2 COVID-19 Virus Like Particle (VLP) Non-US Vaccine Product (Medicago, Covifenz)512 Non-US4/12/2022Pandemic Non-US Vaccine not Authorized by WHO - ACIP does recognize towards immunity in US
Td (adult)tetanus and diphtheria toxoids, not adsorbed, for adult use138 Inactive9/30/2010Note that this Td is not adsorbed.
Td (adult), 2 Lf tetanus toxoid, preservative free, adsorbedtetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (2 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid)09 Active10/27/2017
Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbedtetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (5 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid)113 Active1/25/2024
Td(adult) unspecified formulationTd(adult) unspecified formulation139 Inactive8/27/2019This CVX code allows reporting of a historic vaccination when the formulation is unknown (for example, when recording a Td vaccination when noted on a vaccination card)
Td, adsorbed, preservative free, adult use, Lf unspecifiedtetanus and diphtheria toxoids, adsorbed, preservative free, for adult use, Lf unspecified196 Active8/15/2019Used when Td Lf specification is unknown
Tdaptetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed115 Active5/28/2010
tetanus toxoid, adsorbedtetanus toxoid, adsorbed35 Inactive8/14/2015
tetanus toxoid, not adsorbedtetanus toxoid, not adsorbed142 Inactive8/14/2015
tetanus toxoid, unspecified formulationtetanus toxoid, unspecified formulation112 Inactive9/30/2010
Tick-borne encephalitis vaccine (non-US)Tick-borne encephalitis vaccine (non-US)77 Non-US3/4/2022Non-US vaccine
Tick-borne encephalitis, inactivated, PF, 0.25mLTick-borne encephalitis vaccine, inactivated, preservative free, 0.25mL dose223 Active3/3/2022Pediatric dose vaccine
Tick-borne encephalitis, inactivated, PF, 0.5mLTick-borne encephalitis vaccine, inactivated, preservative free, 0.5mL dose224 Active3/4/2022Adult dose vaccine
Tick-borne encephalitis, unspecifiedTick-borne encephalitis vaccine, unspecified222 Inactive3/16/2022Unspecified Code - should only be used when specific vaccine administered is unknown
tularemia vaccinetularemia vaccine78 Inactive5/28/2010
Typhoid conjugate vaccine (TCV)Typhoid conjugate vaccine (non-US)190 Non-US1/17/2023
typhoid, oraltyphoid vaccine, live, oral25 Active5/28/2010
typhoid, parenteraltyphoid vaccine, parenteral, other than acetone-killed, dried41 Inactive8/13/2015
typhoid, parenteral, AKD (U.S. military)typhoid vaccine, parenteral, acetone-killed, dried (U.S. military)53 Inactive6/18/2015
typhoid, unspecified formulationtyphoid vaccine, unspecified formulation91 Inactive9/30/2010This CVX code allows reporting of a vaccination when formulation is unknown (for example, when recording a typhoid vaccination when noted on a vaccination card)
typhoid, ViCPstyphoid Vi capsular polysaccharide vaccine101 Active5/28/2010
typhus, historicalHistorical record of a typhus vaccination131 Inactive5/28/2010
vaccinia (smallpox)vaccinia (smallpox) vaccine75 Active5/28/2010
vaccinia (smallpox) dilutedvaccinia (smallpox) vaccine, diluted105 Inactive5/28/2010
Vaccinia, smallpox Mpox vaccine live, PF, SQ or ID injectionVaccinia, smallpox monkeypox vaccine, live attenuated, preservative free, subcutaneous or intradermal injection206 Active2/14/2023Associated to FDA US Licensed product JYNNEOS, non-US tradenames IMVANEX, IMVAMUNE. Review CDC & FDA guidance for updates regarding administration
varicellavaricella virus vaccine21 Active5/28/2010
VEE, inactivatedVenezuelan equine encephalitis, inactivated81 Inactive5/28/2010
VEE, liveVenezuelan equine encephalitis, live, attenuated80 Inactive5/28/2010
VEE, unspecified formulationVenezuelan equine encephalitis vaccine, unspecified formulation92 Inactive9/30/2010This CVX code allows reporting of a vaccination when formulation is unknown (for example, when recording a VEE vaccination when noted on a vaccination card)
yellow feveryellow fever vaccine37 Active3/2/2017This is the YF vaccine that has been available in the US for years. It is stabilized with sorbitol and gelatin.
Yellow fever vaccine - altYellow fever vaccine alternative formulation183 Active3/2/2017This vaccine is stabilized with sorbitol and lactose and has been used outside the US for some time. It will be made available in the US.
Yellow fever, unspecified formulationYellow fever vaccine, unspecified formulation184 Inactive3/2/2017
zoster livezoster vaccine, live121 Active5/28/2010
zoster recombinantzoster vaccine recombinant187 Active10/27/2017
zoster, unspecified formulationzoster vaccine, unspecified formulation188 Inactive10/27/2017This CVX code allows reporting of a vaccination when formulation is unknown (for example, when recording a zoster vaccination when noted on a vaccination card)


Non-Vaccines:
Short DescriptionFull Vaccine nameCVX CodeVaccine StatusLast Updated DateNotes
anthrax immune globulinanthrax immune globulin181 Active9/4/2020
AS03 AdjuvantAS03 Adjuvant801 Active10/27/2020This is the adjuvant that is packaged with H5N1 vaccine, adjuvanted
botulinum antitoxinbotulinum antitoxin27 Active9/4/2020
CMVIGcytomegalovirus immune globulin, intravenous29 Active9/4/2020
diphtheria antitoxindiphtheria antitoxin12 Active9/4/2020
HBIGhepatitis B immune globulin30 Active9/4/2020
Hep A, IGHepatitis A immune globulin154 Never Active9/9/2020Do not use this code. This product may be used for Hep A and other viral infections. The correct vaccine / CVX is 86 (IG).
IGimmune globulin, intramuscular86 Active9/4/2020
IG, unspecified formulationimmune globulin, unspecified formulation14 Inactive3/9/2023
IGIVimmune globulin, intravenous87 Active9/4/2020
no vaccine administeredno vaccine administered998 Inactive3/9/2023Code 998 was added for use in VXU HL7 messages where the OBX segment is nested with the RXA segment, but the message does not contain information about a vaccine administration. An example of this use is to report the vaccines due next for a patient when no vaccine administration is being reported.
RESERVED - do not useRESERVED - do not use99 Inactive9/9/2020Code 99 will not be used in this table to avoid confusion with code 999.
Rho(D) - Unspecified formulationRho(D) Unspecified formulation159 Inactive3/9/2023
Rho(D) -IG IMRho(D) Immune globulin - IM157 Active9/4/2020This immune globulin may be administered IM only.
Rho(D)-IGRho(D) Immune globulin- IV or IM156 Active9/4/2020This immune globulin may be administered either IM or IV.
RIGrabies immune globulin34 Active9/4/2020
RSV-IGIVrespiratory syncytial virus immune globulin, intravenous71 Inactive7/19/2023No active NDCs or CPT codes associated to this CVX
RSV-MAbrespiratory syncytial virus monoclonal antibody (palivizumab), intramuscular93 Active9/4/2020
RSV-MAb (new)respiratory syncytial virus monoclonal antibody (motavizumab), intramuscular145 Never Active9/9/2020
Staphylococcus bacterio lysateStaphylococcus bacteriophage lysate76 Inactive3/9/2023
tetanus immune globulintetanus immune globulin180 Inactive9/9/2020This record duplicates CVX 13 (TIG). Do not use CVX 180.
TIGtetanus immune globulin13 Active9/4/2020
TST, unspecified formulationtuberculin skin test; unspecified formulation98 Inactive3/9/2023TB Skin test is not vaccine.
TST-OT tine testtuberculin skin test; old tuberculin, multipuncture device95 Inactive3/9/2023TB Skin test is not vaccine.
TST-PPD intradermaltuberculin skin test; purified protein derivative solution, intradermal96 Inactive3/9/2023TB Skin test is not vaccine.
TST-PPD tine testtuberculin skin test; purified protein derivative, multipuncture device97 Inactive3/9/2023TB Skin test is not vaccine.
unknownunknown vaccine or immune globulin999 Inactive10/27/2020This CVX code has little utility and should rarely be used.
vaccinia immune globulinvaccinia immune globulin79 Active9/4/2020
VZIGvaricella zoster immune globulin36 Active9/4/2020
VZIG (IND)varicella zoster immune globulin (Investigational New Drug)117 Never Active9/9/2020

 Top of Page



For further information on HL7 immunization data exchange and the CVX code set, contact the IIS Technical Assistance Team at:

Address:
CDC, National Centers for Immunization and Respiratory Diseases
Immunization Information System Support Branch - Informatics
1600 Clifton Road
Mailstop: E-62
Atlanta, GA 30333
Email:
iisinfo@cdc.gov (note change)

Page last reviewed: January 31, 2024